Latest News & Features
Americas
Myriad and its rival genetic diagnostics company Gene by Gene have agreed to settle their patent infringement case related to BRCA tests. 13 February 2014
Americas
The US Chamber of Commerce has criticised India’s “recent pattern of pharma patent denials”, which it says “are not about access to medicine”. 12 February 2014
Americas
Pharmaceutical company Merck and Samsung Bioepis, a joint venture between South Korean firm Samsung and Biogen, have agreed to work on a diabetes treatment. 11 February 2014
Americas
The US Court of Appeals for the Federal Circuit has upheld a patent covering Pfizer’s pain drug Lyrica, closing the market to any generic challengers until 2018. 10 February 2014
Asia
Roche’s Indian subsidiary has sued Mylan and Bangalore-based pharmaceutical company Biocon at the Delhi High Court, for launching a biosimilar of its breast cancer drug Herceptin (trastuzumab). 7 February 2014
Americas
Myriad Genetics has entered into a definitive agreement to acquire inflammatory and autoimmune diagnostics company Crescendo Bioscience for $270 million. 6 February 2014
Americas
Law firm Baker & McKenzie has hired pharmaceutical lawyer Julian Thurston as a consultant in its global pharmaceutical and healthcare industry group. 5 February 2014
article
UK IP law firm Powell Gilbert has appointed solicitor and medical doctor Tess Waldron as an associate. 30 January 2014
Americas
A US medical research foundation has received about $131.2 million in damages after a jury found that two of its patents covering cochlear implants were infringed. 29 January 2014
Americas
Healthcare company Covidien PLC has been told it did not infringe patents belonging to a Johnson & Johnson-owned company through using its ultrasonic dissection device. 29 January 2014